Walter Investment Management is Now Oversold (WAC)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Thursday, shares of Walter Investment Management Corp ( WAC) entered into oversold territory, hitting an RSI reading of 25.6, after changing hands as low as $17.04 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 62.6. A bullish investor could look at WAC's 25.6 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of WAC shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

Walter Investment Management Corp 1 Year Performance Chart

Looking at the chart above, WAC's low point in its 52 week range is $15.9401 per share, with $40.12 as the 52 week high point — that compares with a last trade of $16.80.

According to the ETF Finder at ETF Channel, WAC makes up 2.01% of the SPDR S&P Capital Markets ETF ( KCE) which is trading lower by about 0.4% on the day Thursday.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says